BioCentury
ARTICLE | Clinical News

NeXstar regulatory update

May 30, 1995 7:00 AM UTC

NeXstar Pharmaceuticals Inc. (NXTR) AmBisome, the Boulder, Colo., company's liposomal formulation of amphotericin B, received marketing approval in Israel to treat life-threatening systemic fungal in...